A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

類似資料

• Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
  著者:: Tai, Wanbo, 等
  出版事項: (2020)
• Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
  著者:: Tai, Wanbo, 等
  出版事項: (2020)
• Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
  著者:: Du, Lanying, 等
  出版事項: (2011)
• Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
  著者:: Jiang, Shibo, 等
  出版事項: (2020)
• Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
  著者:: Wang, Yufei, 等
  出版事項: (2017)